Zobrazeno 1 - 10
of 47
pro vyhledávání: '"S A, Kubo"'
Autor:
Jason M. Duran, Catherine A. Makarewich, Mary F. Barbe, E B S Thomas Sharp Iii, Sharven Taghavi, B S Hajime Kubo, M B S Remus Berretta, Timothy Starosta, Steven R. Houser
Publikováno v:
Clinical and Translational Science. 8:425-431
Background Cardiac- (CSC) and mesenchymal-derived (MSC) CD117+ isolated stem cells improve cardiac function after injury. However, no study has compared the therapeutic benefit of these cells when used autologously. Methods MSCs and CSCs were isolate
Autor:
Jie Wang, Tetsuro Izumi, S.-K. Kubo, Hiroyuki Kuwano, H. Yokota, Toshiyuki Takeuchi, Yukio Nagamachi, Isao Hirayama, Hiroyuki Tamemoto
Publikováno v:
Diabetes. 48:1237-1244
The receptor-type protein tyrosine kinases in murine pancreatic islets were screened to identify possible growth/differentiation factors in pancreatic beta-cells. The analysis revealed that insulin receptor-related receptor (IRR) is highly expressed
Publikováno v:
Scopus-Elsevier
OBJECTIVE To determine whether pancreas transplant recipients maintain normal blood glucose levels during physical exercise. RESEARCH DESIGN AND METHODS We measured serum glucose, insulin, C-peptide, and plasma glucagon levels in six pancreas transpl
Autor:
Denise C. Fernandes, Eduardo Ferreira Borba, Irineu Tadeu Velasco, Rui Curi, Daniella Oxer, Francisco R.M. Laurindo, Luiz C. Godoy, Denise Frediani Barbeiro, Ieda Maria Magalhães Laurindo, Heraldo Possolo de Souza, Thais Martins de Lima-Salgado, Eloisa Bonfa, S. K. Kubo, Luiz Augusto Corrêa Passos
Publikováno v:
Lupus. 20(6)
Systemic lupus erythematosus (SLE) is a heterogeneous disease involving several immune cell types and pro-inflammatory signals, including the one triggered by binding of CD40L to the receptor CD40. Peroxisome-proliferator activated receptor gamma (PP
Autor:
Marisa Passarelli, Edna Regina Nakandakare, R. S. Pinto, Sergio Catanozi, S. K. Kubo, L. S. Okuda, Eder Carlos da Rocha Quintão, D. D. F. M. Rocco, F.D. Ferreira
Publikováno v:
Lipids. 46(7)
We analyzed the effect of a 6-week aerobic exercise training program on the in vivo macrophage reverse cholesterol transport (RCT) in human cholesteryl ester transfer protein (CETP) transgenic (CETP-tg) mice. Male CETP-tg mice were randomly assigned
Publikováno v:
Journal of Applied Physiology. 73:1637-1643
We have previously reported a fivefold increase of plasma atrial natriuretic factor (ANF) in patients with congestive heart failure (CHF) compared with normal subjects. However, given the marked increase of ANF under basal conditions, the extent to w
Autor:
S I, Kubo, T, Kitami, S, Noda, H, Shimura, Y, Uchiyama, S, Asakawa, S, Minoshima, N, Shimizu, Y, Mizuno, N, Hattori
Publikováno v:
Journal of neurochemistry. 78(1)
We recently identified a novel gene, parkin, as a pathogenic gene for autosomal recessive juvenile parkinsonism. Parkin encodes a 52-kDa protein with a ubiquitin-like domain and two RING-finger motifs. To provide a insight into the function of parkin
Publikováno v:
Clinical transplantation. 10(6 Pt 1)
As the proportion of people over age 60 in our society continues to rise, so does the number of potential heart transplant candidates. Advanced recipient age, however, has long been used as an exclusion criterion for transplantation, though the upper
Autor:
M R, Bristow, E M, Gilbert, W T, Abraham, K F, Adams, M B, Fowler, R E, Hershberger, S H, Kubo, K A, Narahara, H, Ingersoll, S, Krueger, S, Young, N, Shusterman
Publikováno v:
Circulation. 94(11)
We conducted a multicenter, placebo-controlled trial designed to establish the efficacy and safety of carvedilol, a "third-generation" beta -blocking agent with vasodilator properties, in chronic heart failure.Three hundred forty-five subjects with m
Autor:
J B, Kostis, B, Shelton, G, Gosselin, C, Goulet, W B, Hood, R M, Kohn, S H, Kubo, E, Schron, M B, Weiss, P W, Willis, J B, Young, J, Probstfield
Publikováno v:
American heart journal. 131(2)
In the Studies of Left Ventricular Dysfunction (LVD), enalapril or placebo was administered in a double-blind fashion to 6797 participants with ejection fractionor = 0.35. During 40 months' average follow-up, 28.1% of participants randomized to enala